Scott Powers
Affiliations: | Applied Mathematics and Statistics | Stony Brook University, Stony Brook, NY, United States |
Area:
StatisticsGoogle:
"Scott Powers"Children
Sign in to add trainee| Rebecca A. Kohnz | grad student | 2010 | SUNY Stony Brook |
| Megha Rajaram | grad student | 2012 | SUNY Stony Brook |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rao M, Nemajerova A, Li J, et al. (2019) Abstract A42: Single-cell RNA-seq analysis of human pancreatic ductal adenocarcinoma identifies a novel cell type expressing the intestinal stem cell marker OLFM4 Cancer Research. 79 |
| Rao M, Powers S. (2018) Tandem Duplications May Supply the Missing Genetic Alterations in Many Triple-Negative Breast and Gynecological Cancers. Cancer Cell. 34: 179-180 |
| Choi M, Bien H, Mofunanya A, et al. (2017) Challenges in Ras therapeutics in pancreatic cancer. Seminars in Cancer Biology |
| Zhao X, Powers S. (2017) New Views into the Genetic Landscape of Metastatic Breast Cancer. Cancer Cell. 32: 131-133 |
| Chen M, Nowak DG, Narula N, et al. (2017) The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. The Journal of Cell Biology |
| Lee HJ, Li CF, Ruan D, et al. (2016) The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation. Molecular Cell |
| Scott KL, Powers S. (2016) Functionally Assessing Candidate Drivers Advances Precision Cancer Medicine. Cancer Cell. 30: 187-189 |
| Powers S, Pollack RE. (2016) Inducing stable reversion to achieve cancer control. Nature Reviews. Cancer. 16: 266-70 |
| Li J, Sordella R, Powers S. (2016) Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas. Scientific Reports. 6: 27891 |
| Escobar-Hoyos L, Vanner EA, Schechter S, et al. (2016) Abstract B76: Translating keratin 17 status to stratify clinically relevant pancreatic cancer heterogeneity and survival Cancer Research. 76 |